BACILLUS SUBTILIS CSY191 STRAIN AND PROBIOTICS CONTAINING THE STRAIN

摘要

PURPOSE: A novel Bacillus CSY191 is provided to effectively suppress the growth of microorganisms and to ensure anticancer activity. CONSTITUTION: A Bacillus subtilis CSY191(deposit number KACC91473P) has acid resistance, bile acid tolerance, and antibacterial property against to food borne microbes. The food borne microbes are Escherichia coli, Pseudomonas aeruginosa, Salmonella enterica, Salmonella enteritidis, Salmonella typhymurium, Shigella flexineri, Shigella sonnei, Bacillu scereus, Listeria ivanovii, Listeria monocytogenes, Stephylococcus aureus or Stephyiococcus epiderimidis. A probiotic formulation contains the Bacillus subtilis CSY191(deposit number KACC91473P) of culture thereof as an active ingredient. A composition with cancer cell toxicity contains the strain or culture thereof as an active ingredient.